Erratum to: J Cancer Surviv
DOI 10.1007/s11764-010-0141-y
The references in the original article have been published incorrectly. The correct version is provided below.
References
American Cancer Society. Colorectal cancer facts and figures 2008–2010. 2009.
Gross CP. Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc. 2006;54(12):1898–904.
Yancik R. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study. Cancer. 1998;82(11):2123–34.
Ries LAG, Melbert D, Krapcho M, Stinchcomb DG, Howlader N, Horner MJ et al. SEER Cancer Statistics Review, 1975–2005. 2007.
Williams JC. Colon carcinoma and diabetes mellitus. Cancer. 1984;54(12):3070–1.
O’Mara BA. Diabetes mellitus and cancer risk: a multisite case-control study. J Chron Dis. 1985;38(5):435–41.
La VC. Diabetes mellitus and colorectal cancer risk. Cancer Epidemiol Biomark Prev. 1997;6(12):1007–10.
La VC. History of selected diseases and the risk of colorectal cancer. Eur J Cancer. 1991;27(5):582–6.
Nilsen TI. Prospective study of colorectal cancer risk and physical activity, diabetes, blood glucose and BMI: exploring the hyperinsulinaemia hypothesis. Br J Cancer. 2001;84(3):417–22.
Meyerhardt JA. Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol. 2003;21(3):433–40.
Barone BB, Yeh HC, Snyder CF, et al. Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA. 2008;300:2754–64.
Siddiqui AA. Elevated HbA1c is an independent predictor of aggressive clinical behavior in patients with colorectal cancer: a case-control study. Dig Dis Sci. 2008;53(9):286–94.
Keating NL. Quality of diabetes care among cancer survivors with diabetes. Med Care. 2007;45(9):869–75.
Wattacheril J. Lagtimes in diagnosis and treatment of colorectal cancer: determinants and association with cancer stage and survival. Aliment Pharmacol Ther. 2008;28(9):1166–74.
Deyo RA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992;45(6):613–19.
Arnold N, Sohn M, Maynard C, Hynes DM. VIReC technical Report 2: VANDI Mortality Data Merge Project. 4-9-2006.
El-Serag HB. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes. Gastroenterology. 2009;136(5):1601–8.
Polednak AP. Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev. 2006;30(5):466–72.
Shonka NA. Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol. 2006;23(4):515–19.
Kerr EA. Making performance indicators work: experiences of US Veterans Health Administration. BMJ. 2007;335(7627):971–3.
Jha AK. Effect of the transformation of the Veterans Affairs Health Care System on the quality of care. N Engl J Med. 2003;348(22):2218–27.
Nattinger AB. Geographic variation in the use of breast-conserving treatment for breast cancer. N Engl J Med. 1992;326(17):1102–7.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found at http://dx.doi.org/10.1007/s11764-010-0141-y.
Rights and permissions
About this article
Cite this article
Chiao, E.Y., Nimbi, P.V. & Naik, A.D. Erratum to: The impact of diabetes process and outcome quality measures on overall survival in patients with co-morbid colorectal cancer. J Cancer Surviv 5, 113 (2011). https://doi.org/10.1007/s11764-010-0158-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11764-010-0158-2